Internship

Intern - Analytical Chemistry

Confirmed live in the last 24 hours

Regeneron Pharmaceuticals

Regeneron Pharmaceuticals

10,001+ employees

Develops medicines for serious diseases

Biotechnology
Healthcare

Compensation Overview

$17 - $48.5Hourly

Tarrytown, NY, USA

Category
Bioinformatics
Biology Lab & Research
Biology & Biotech

You match the following Regeneron Pharmaceuticals's candidate preferences

Employers are more likely to interview you if you match these preferences:

Degree
Experience
Requirements
  • Enrolled in or accepted to an academic program pursuing a Graduate degree in Chemistry, Biochemistry, Analytical Chemistry, or related majors
  • Experience with Mass Spectrometry, Liquid Chromatography, and Protein Chemistry
  • Cumulative GPA of 3.0 preferred
  • Ability to commit to 40 hours per week for a minimum of 10 weeks from the end of May/early June through August
Responsibilities
  • Achieving a general understanding of what happens in our global organization
  • Completing hands-on project work that has an impact on the business
  • Engaging with Regeneron leadership
  • Collaborating with a specific hiring manager and other interns
  • Establishing connections with Regeneron’s diverse set of employee resource groups
  • Participating in professional development sessions while enjoying lots of free food and swag
  • Showcasing the knowledge gained through end of program presentation sessions
  • Getting paid for hard work
Desired Qualifications
  • Demonstrated leadership in areas such as campus activities, clubs, sports, current or previous work, or within the community preferred
Regeneron Pharmaceuticals

Regeneron Pharmaceuticals

View

Regeneron Pharmaceuticals develops medicines aimed at treating serious diseases such as cancer, eye diseases, and allergic conditions. The company uses its own technologies and extensive research to create new therapies, often collaborating with academic institutions and other pharmaceutical companies to enhance its efforts. Unlike many competitors, Regeneron focuses on both research and commercialization, generating revenue through the sale of its approved medicines and licensing its technologies. The goal of Regeneron is to improve patient outcomes by providing effective treatments and ensuring that its products meet high safety and efficacy standards.

Company Stage

IPO

Total Funding

$684M

Headquarters

Town of Greenburgh, New York

Founded

1988

Simplify Jobs

Simplify's Take

What believers are saying

  • Growing antibody therapy market offers expansion opportunities for Regeneron.
  • Investment in Truveta's genome project accelerates personalized medicine initiatives.
  • Acquisition of Oxular strengthens Regeneron's position in retinal disorder treatments.

What critics are saying

  • Class action lawsuit may lead to financial liabilities and reputational damage.
  • Truveta investment might not yield expected returns, posing financial risk.
  • Integration challenges with Oxular could affect operational efficiency.

What makes Regeneron Pharmaceuticals unique

  • Regeneron leverages proprietary technologies for innovative therapies in serious diseases.
  • Strategic collaborations enhance Regeneron's research and development capabilities.
  • Regeneron's focus on eye diseases and monoclonal antibodies sets it apart.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Wellness Program

Paid Vacation

Equity Awards

Annual Bonuses

Flexible Work Hours